About this project

Pharma and CDMO investment of € 200 mln by Sanofi at Industriepark Höchst in Germany, Europe, targeting the production of Insulin.

Investment details


Industriepark Höchst

Frankfurt-Höchst , Hessen, Germany
Total area: 460.0ha
Free: 50.0ha
Amount € 200 mln
Target substances
Insulin Product
Detailed data on 1200+ projects in Europe
Chemical substances Chemical plants Chemical companies Investment projects
PIPS Chemical Insights